(Q36328945)

13 August 2017

1 reference

title

Hepatitis C virus infection in African Americans (English)

1 reference

13 August 2017

1 reference

1 reference

Brian L Pearlman

1

1 reference

13 August 2017

language of work or name

English

0 references

publication date

29 November 2005

1 reference

Clinical Infectious Diseases

13 August 2017

published in

1 reference

13 August 2017

volume

42

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

82-91

1 reference

Epidemiology of hepatitis C

13 August 2017

cites work

1 reference

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

21 January 2018

1 reference

Ethnic and racial differences in diabetes care: The Insulin Resistance Atherosclerosis Study

21 January 2018

1 reference

Barriers to the participation of African-American patients with cancer in clinical trials: a pilot study

21 January 2018

1 reference

The medicalization of race: scientific legitimization of a flawed social construct

21 January 2018

1 reference

Hepatitis B and hepatitis C in emergency department patients

21 January 2018

1 reference

45-year follow-up of hepatitis C virus infection in healthy young adults

21 January 2018

1 reference

Hepatitis C infection in African Americans: its natural history and histological progression

21 January 2018

1 reference

Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C. The International Hepatitis Interventional Therapy Group

21 January 2018

1 reference

Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. Sentinel Counties Viral Hepatitis Study Team

21 January 2018

1 reference

Hepatitis C in African Americans: summary of a workshop

21 January 2018

1 reference

Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection

21 January 2018

1 reference

The natural history of hepatitis C virus infection: host, viral, and environmental factors

21 January 2018

1 reference

Chronic hepatitis C in ethnic minority patients evaluated in Los Angeles County

21 January 2018

1 reference

Racial differences in liver inflammation and fibrosis related to chronic hepatitis C.

21 January 2018

1 reference

A comparison of the spectrum of chronic hepatitis C virus between Caucasians and African Americans

21 January 2018

1 reference

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

21 January 2018

1 reference

Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C

21 January 2018

1 reference

Analysis of successful immune responses in persons infected with hepatitis C virus

21 January 2018

1 reference

Influence of ethnicity in the outcome of hepatitis C virus infection and cellular immune response

21 January 2018

1 reference

Racial differences in HLA class II associations with hepatitis C virus outcomes

21 January 2018

1 reference

Single nucleotide polymorphisms and haplotypes in the IL10 region associated with HCV clearance

21 January 2018

1 reference

Hepatocellular carcinoma: recent trends in the United States

21 January 2018

1 reference

African Americans with genotype 1 treated with interferon for chronic hepatitis C have a lower end of treatment response than Caucasians

21 January 2018

1 reference

Chronic hepatitis C in African Americans and other minority groups

21 January 2018

1 reference

Differences in treatment outcome for hepatitis C among ethnic groups

21 January 2018

1 reference

Peginterferon alfa-2a in patients with chronic hepatitis C.

21 January 2018

1 reference

A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C.

21 January 2018

1 reference

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites

21 January 2018

1 reference

Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1.

21 January 2018

1 reference

Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

21 January 2018

1 reference

Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa

21 January 2018

1 reference

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

21 January 2018

1 reference

Viral dynamics and response differences in HCV-infected African American and white patients treated with IFN and ribavirin

21 January 2018

1 reference

Racial differences in the relationship between hepatitis C infection and iron stores

21 January 2018

1 reference

Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C.

21 January 2018

1 reference

Hepatitis C virus and human immunodeficiency virus coinfection in an urban population: low eligibility for interferon treatment

21 January 2018

1 reference

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

21 January 2018

1 reference

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/498512

1 reference

13 August 2017

1 reference